January 23, 2017 — Over 93 percent of heart attack patients are receiving stents within the guideline-recommended...
Structural Heart Occluders
This channel includes news and new technology innovations about structural heart occluders. These include information of surgical repair and transcatheter closure of PFO, VSD, ASD and LAA. Devices include the Amplatzer and the Gore Helex
Feature | Left Atrial Appendage (LAA) Occluders | November 07, 2016
November 7, 2016 – Results from the U.S. real-world, post-FDA approval experience of the Watchman device found high...
News | Structural Heart Occluders | November 02, 2016
November 2, 2016 — St. Jude Medical Inc. announced the long-term data from RESPECT, a landmark trial, during a First...
Technology | Structural Heart Occluders | November 02, 2016
November 2, 2016 — St. Jude Medical Inc. announced this week the U.S. Food and Drug Administration (FDA) approval...
News | Congenital Heart | October 19, 2016
October 19, 2016 — St. Jude Medical Inc. announced the launch of the ADO II AS (AMPLATZER Duct Occluder II...
News | Left Atrial Appendage (LAA) Occluders | September 02, 2016
September 2, 2016 — St. Jude Medical Inc. announced the start of the St. Jude Medical Amplatzer Amulet IDE trial of...
News | Structural Heart Occluders | August 08, 2016
August 8, 2016 — Updated recommendations from the American Academy of Neurology (AAN) states that catheter-based...
An illustration of a Watchman transcatheter LAA occluder being implanted.
Feature | Left Atrial Appendage (LAA) Occluders | August 01, 2016 | Dave Fornell
Patients with atrial fibrillation (AF or Afib) are high risk for stroke due to the formation of thrombus emboli in...
Videos | Structural Heart Occluders | June 16, 2016
This is an animation, supplied by Gore, demonstrated how the Cardioform Septal Occluder is implanted for the...
Feature | Structural Heart Occluders | May 27, 2016 | Dave Fornell
May 27, 2016 — A U.S. Food and Drug Administration (FDA) panel recommended approval of a transcatheter patent...
The Boston Scientific Watchman device is currently the only transcatheter LAA occluder cleared for use in the United States.
Feature | Left Atrial Appendage (LAA) Occluders | May 20, 2016 | Dave Fornell
Atrial fibrillation (AF) affects nearly 6 million Americans and the condition puts them at significantly greater...
Videos | Left Atrial Appendage (LAA) Occluders | April 15, 2016
David Holmes, M.D., professor of medicine, Mayo Clinic College of Medicine and consultant, Department of Internal...
Technology | Left Atrial Appendage (LAA) Occluders | February 09, 2016
February 9, 2016 — Boston Scientific Corp. announced the Centers for Medicare and Medicaid Services (CMS) will cover...
Transcatheter repair of a surgical mitral replacement paravalvular leak with an Amplatzer Vascular Plug II.
Feature | Heart Valve Technology | February 08, 2016 | Dave Fornell
Off-label use of the St. Jude Amplatzer vascular plug devices offers a new solution for the minimally invasive...
News | Structural Heart | January 20, 2016
January 20, 2016 — On the 100th anniversary of the Endurance expedition to Antarctica led by Sir Ernest Shackleton,...
